Peer Review History
| Original SubmissionJanuary 28, 2021 |
|---|
|
PONE-D-21-03073 Neuroinflammation, body temperature and behavioural changes in CD1 Male Mice Undergoing Acute Restraint Stress: an Exploratory Study. PLOS ONE Dear Dr. Calvillo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please refer to editorial recommendations by both reviewer 1 and 2. In particular, addressing reviewer 1's concerns about a lack of discussion of confounding effects and the underpowered nature of the study are essential revisions to be made. Please submit your revised manuscript by May 27 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kimberly R. Byrnes, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements.
https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and
The authors have declared that no competing interests exist. We note that one or more of the authors are employed by a commercial company: Research & Services Dept, E.m.c2 srl, Varese, Italy. 3a, Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 3b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a very interesting study to determine the impact of several factors common to animal handling that might impact study outcome. In particular, the authors focused on: 1. impact of bright light (500 lux) and 15 min restraint, procedures common to injections and type of handling (tail hold, tunnel or mechanoreceptive handling). While the overall intent of the study is laudatory, there are some concerns. Unfortunately, the manuscript is underdeveloped. It is difficult to evaluate the study as it stands and require significant revisions before being properly evaluated. The experimental design is confusing - there are many factors that come into play and are not well controlled. The data presented does not show all the behavioral outcomes measured (1st after handling and 2nd after stress stimuli/handling). There is also no discussion of how each of the treatments (handling or stress) might have confounding effects. Additional concerns are listed below: 1. The authors conducted the study using various non-parametric tests. More significantly, the authors used a power analysis centering on chemokine data to determine the number of replicates per treatment group. For this study, the authors should be using the behavioral outcomes to determine the number of replicates. It would appear from the figures and the raw data that the study lacks power. Figures 3, 4 and 8 all have very large error bars (not mentioned if this is standard deviation or error). In addition, the error bars in these figures are unusual - the upper and the lower error bars are different sizes. Its unclear how that can happen. 2. There is a lot of gaps in the methods. CXCL12 and CCL2 were quantified using an ELISA. What is the intra- and inter-assay CV? What is the sensitivity of the assay for each of the markers? 3. Immunohistochemistry - no controls were included in the figure. Was the antibody pre-absorbed? How was the antibody characterized? The low magnification image makes it difficult to evaluate whether the positive signals are real and not background noise - a 40X magnification is a minimum for this Iba1. 4. Elevated plus maze study. It is important to be sure that the baseline is at least 20-30% in the open arms compared to the overall (ie 60-90 s of 300 s). As it stands, the EPM data is not so valid. 5. More details are needed to the sequence of when the studies were conducted relative to each other. 6. There is no mention of when the studies are conducted during the light cycle and relative to zeitgeber (such as lights on or lights off). This is important as it affects the EPM data, body weight (is it right after main feeding?), nest building - affected by diurnal time etc. 7. The overall paper can be better develop and edited. Reviewer #2: Redaelli and colleagues describe numerous physiological and behavioral effects of acute (15 min) restraint stress on mice that were handled using three different techniques, conventional tail handling, mechanoceptive handling and the non-invasive tunnel handling method. The authors provide a clear rationale for these studies, namely that the physiological and behavioral effects induced by routine procedural use of restraint under bright light conditions may induce variability in results of subsequent endpoints of interest and increase the number required per group due to this variability. Specifically, acute restraint stress reduced body temperature, produce a cessation in body weight gain, increased grooming behavior and decreased naturalistic behaviors in the home cage. No significant restraint induced changes in bone marrow chemokines, activated microglial number in the PVN and entire brain, or on nesting behavior. Furthermore, the authors demonstrate that tunnel handling mitigates the effects of the acute restraint stress/bright light conditions. Overall the methods are clear and the interpretation of data is appropriate. The manuscript would be of interest to the general readership of PLOS One. There are some concerns/comments that the authors may wish to address. Concerns/Comments Regarding the statistical analysis, it is somewhat difficult to draw direct comparisons between the handling groups using non-parametric Mann Whitney within subjects’ evaluation of stress for each given handling technique. If you normalize the data and use Kruskal Wallis, you may wish to compute the effect size for Kruskal-Wallis test as the eta squared based on the H-statistic. That effect size will be a more objective method to compare between handling groups. In the introduction, the authors suggest that chronic restraint is a well-established model to produce post-traumatic stress disorder or model depression. It is not really appropriate to say it produces PTSD, rather that it may induce behaviors that have relevance to the clinical conditions of PTSD and major depressive disorder. Only male animals are used in this study. Is there evidence in the literature that show that females respond similarly to males in terms of stress responsivity following tunnel handling? It would be appropriate to add to the discussion to address the issue of sex as a biological variable. Useful reference include Sensini et al2020, DOI: 10.1038/s41598-020-74279-3 and Gouveia and Hurst 2019, DOI: 10.1038/s41598-019-56860-7, which is already referenced in this manuscript. It may be useful to measure peripheral corticosterone levels in these animals to use as another physiological measure. I would expect that your tunnel handled animals may not have as high levels. Another control would be tail handled animals that are intermittently but repeatedly exposed to the restraint device. Would there be habituation of the behavioral effects observed in such animals. Methods • It would be helpful to explicitly state how the animals were transferred to the experimental apparatus. I assume sentinels were transferred by tail handling. • With regards to the use of sentinels as control animals, were these animals exposed to other pathogens etc. in the room? Are they housed specifically on the same rack as the experimental animals? • To improve the flow of the manuscript, handling methods should come directly after husbandry. • Move the following information from the experimental design to the statistical section – “The numerosity within the groups derived from a power calculation for CXCL12 chemokine concentration in the BM (software available at http://www.biomath.info/). On the base of the literature, a standard deviation of 50 and a difference of 70 pg/ml was expected between groups to have an alpha value less than 0,05 and a power of 0,80.” • For the nesting procedure, 30 seconds is a very short duration in which to observe construction of a nest. Were the additional scores observed at later time points? There may have been a delay in the onset of nesting building, and this would be more informative than a snap shot just after nesting material presentation or 24 h totals of nesting. I would draw your attention to newer publications that utilize nesting as a behavioral endpoint, for example Jacobson 2020 DOI: 10.1016/j.neuropharm.2020.108254. In that study, nesting was evaluated over a 5 hour period. Also, please clarify in the methods whether the statistical analysis was conducted on nest score at 24 h. • For body weight, data is represented in grams. It perhaps may be most useful to have a normalized value of weight gain/weight loss. Using the percentage of body weight is a useful transformation for statistical analysis between groups. • It is always difficult to interpret repeated assays of anxiety measures. It is most common that upon repeated testing animals tend to explore more as the aversive quality of the neophobia is diminished. This might explain some of the variance in the post stress time spent in the open arms. Have you considered transforming the data as ratio of post/pre stress? Results/Figures • For the data which was analyzed with Kruskal Wallis, please provide the H values. • Provide the actual values for nesting in the results section and also in Figure 2. The photographs of the nests are appropriate, but the data should be included in that figure. • Figure 5 - please place the appropriate symbols that indicate the significant effects of stress/handling on grooming and other parameters. • Figure 10 - only one photomicrograph of Iba1+ immunoreactivity is provided. Please provide the data obtained from all groups and a representative photomicrograph for each handling group. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-03073R1 Neuroinflammation, body temperature and behavioural changes in CD1 Male Mice Undergoing Acute Restraint Stress: an Exploratory Study. PLOS ONE Dear Dr. Calvillo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please pay particular attention to the request of reviewer 1 to provide additional controls for data analysis and interpretation. Please submit your revised manuscript by Aug 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kimberly R. Byrnes, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I thank the authors for the improved manuscript. Figure 1 is helpful in interpreting the experiment conducted. There are still a few points of concern: 1. NEW. It is unclear when the behavioral tests and samples were collected during the light phase of the day (0600 - 1800 h). Is it consistent? It makes a difference if it is close to the transitions (ie 0600 - ~ 0800 h and 1500 - ~1800 h) for the mice. Since this is a NC3R study, the authors should also state what time of the day the vivarium caretakers enter the room as this can also have an impact on the study. 2. The authors made a very good counter argument about the very low baseline time in open arms (significantly less than 20-30%). However, the data does not reflect their argument. There should be parallel changes in open arm time and open arm entry. I am okay to waive the 20-30% baseline but the authors should show that the mice were actively exploring. In addition to the measures in Table 3A, it would be good to include activity in the open arm and activity in the closed arm. Other measures of exploration are head dip, sniffing etc. 3. Immunohistochemistry. The 40X is an improvement. Thank you. Regarding controls for the Iba1+ cells, the authors still did not address what controls they used. Controls for immunohistochemistry typically includes: 1. removal of primary antibody, 2. preabsorption of the antibody using a peptide (this should be easy to purchase or synthesize) or 3. use a Iba1 knockout mouse. The third option is idea but not always possible. Option #2 is the more commonly used option. The reason it is necessary to conduct a negative control is that immunohistochemistry is sensitive to many subtle changes in protocol - fixative, antigen retrieval etc etc etc. These subtle changes can cause changes to the epitope which can lead to false positives or partial positives/negatives. 4. NEW. More details are needed for where Iba1+ cells were counted. More details are needed to define the PVN and the entire section posterior to the midpoint of the brain. More typical details include: 1. using a stereotaxic atlas to provide the coordinates (rostro-caudal and lateral) for what you are looking at and 2. a photomicrograph of the region of interest that is outlined. In addition, more information is also needed to how the authors measured the Iba+ cells in a non-biased manner. 5. NEW. In the response to reviewers, the authors state that "an image at high magnification (40X) will allow to make evident the well delineated signal in the cell body and in the dendrites." Microglia do not have dendrites. Reviewer #2: Please ensure that the term sex is used throughout the manuscript not sex. Your mice have a sex, they do not have a gender. Tables & Figures – with regard to presentation of the data. It would be best to present the data for the sentinels (true controls) in the first line. If the data are presented as a figure it is not necessary to present a table also, for example Table 3b contains the same information as presented in figure 8. Table 2 – data from TH animals were not included here, so perhaps you may wish to omit this line from the table to avoid confusion. Figures 3 and 4 should be combined into one Figure. The data for the nesting behavior has not been added in table or figure format. For the EPM it is not conventional to use the term fold increase. Rather choose a better descriptor, such as ratio of post/pre, or normalized to prestress baseline. There remains a number of grammatical and typographical errors. The manuscript would benefit from editing by a native English speaker. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Neuroinflammation, body temperature and behavioural changes in CD1 Male Mice Undergoing Acute Restraint Stress: an Exploratory Study. PONE-D-21-03073R2 Dear Dr. Calvillo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kimberly R. Byrnes, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Thank you for addressing these comments. Table 2 has been updated adequately. The nesting scores are very helpful to have in the table form and the data from the EPM are explained very well. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No |
| Formally Accepted |
|
PONE-D-21-03073R2 Neuroinflammation, body temperature and behavioural changes in CD1 Male Mice Undergoing Acute Restraint Stress: an Exploratory Study. Dear Dr. Calvillo: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kimberly R. Byrnes Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .